Loading...
Please wait, while we are loading the content...
Similar Documents
HOXC13-AS-miR-122-5p-SATB1-C-Myc feedback loop promotes migration, invasion and EMT process in glioma
| Content Provider | Scilit |
|---|---|
| Author | Liu, Ning Wang, Ziyu Liu, Dachao Xie, Peng |
| Copyright Year | 2019 |
| Description | Journal: OncoTargets and therapy Purpose: Differentially expressed long non-coding ribonucleic acids (lncRNAs) have been reported as a key factor of glioma carcinogenesis, but the underlying mechanism involved is still unknown. Materials and methods: In the present study, lncRNA HOXC13 antisense RNA (HOXC13-AS) was identified as a potential oncogene in glioma, and Western blotting, wound healing and Transwell assays were carried out to explore the effects of HOXC13-AS on the epithelial-mesenchymal transition (EMT) process as well as the migration and invasion of glioma cells. Results: A further mechanistic study showed that HOXC13-AS sponged miR-122-5p to indirectly regulate SATB1 expression and affect the EMT process via the Wnt/β-catenin pathway. Meanwhile, the promoter activity was significantly increased via c-Myc, a key factor of the Wnt/β-catenin pathway, thus forming a positive HOXC13-AS-miR-122-5p-SATB1-c-Myc feedback loop to drive the malignant behavior in glioma. Discussion: This study evidences the constitutive HOXC13-AS-miR-122-5p-SATB1-c-Myc feedback loop and provides a potential therapeutic target for glioma treatment. |
| Related Links | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6731462/pdf https://www.dovepress.com/getfile.php?fileID=52444 |
| Ending Page | 7173 |
| Page Count | 9 |
| Starting Page | 7165 |
| ISSN | 11786930 |
| DOI | 10.2147/ott.s220027 |
| Journal | OncoTargets and therapy |
| Volume Number | ume 12 |
| Language | English |
| Publisher | Informa UK Limited |
| Publisher Date | 2019-09-01 |
| Access Restriction | Open |
| Subject Keyword | Journal: OncoTargets and therapy Competing Endogenous Rna Epithelial-mesenchymal Transition |
| Content Type | Text |
| Subject | Pharmacology (medical) Oncology |